Market Report, "BioTime, Inc. (BTX) - Product Pipeline Analysis, 2014 Update", Published
BioTime, Inc. (BioTime) is a biotechnology company. It is focused on research and development in the field of regenerative medicine. The company's products can be used in various fields of medicine such as oncology, neuroscience, orthopedics and blood and vascular diseases. It is developing medicines using pluripotent stem technology that is based on induced pluripotent stem (iPS) cells and human embryonic stem (hES) cells. The company is developing PureStem cell lines and associated ESpan culture media, HyStem hydrogels and human...
View full press release